Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CADL |
---|---|---|
09:32 ET | 4971 | 7.13 |
09:34 ET | 2682 | 7.12 |
09:36 ET | 2000 | 7.16 |
09:38 ET | 458 | 7.08 |
09:43 ET | 7810 | 7.12 |
09:45 ET | 1857 | 7.075 |
09:48 ET | 442 | 7.13 |
09:57 ET | 100 | 7.09 |
10:01 ET | 600 | 7.135 |
10:03 ET | 605 | 7.15 |
10:06 ET | 619 | 7.14 |
10:10 ET | 100 | 7.105 |
10:12 ET | 3405 | 7.14 |
10:14 ET | 200 | 7.15 |
10:15 ET | 1583 | 7.23 |
10:17 ET | 2100 | 7.22 |
10:21 ET | 700 | 7.15 |
10:35 ET | 140 | 7.165 |
10:39 ET | 203 | 7.18 |
10:51 ET | 199 | 7.1676 |
11:00 ET | 830 | 7.18 |
11:02 ET | 1230 | 7.19 |
11:04 ET | 700 | 7.23 |
11:06 ET | 536 | 7.22 |
11:08 ET | 537 | 7.24 |
11:13 ET | 1764 | 7.21 |
11:15 ET | 958 | 7.18 |
11:22 ET | 1750 | 7.18 |
11:24 ET | 140 | 7.175 |
11:33 ET | 200 | 7.125 |
11:58 ET | 3900 | 7.09 |
12:05 ET | 800 | 7.13 |
12:18 ET | 800 | 7.12 |
12:36 ET | 600 | 7.06 |
12:52 ET | 100 | 7.06 |
12:59 ET | 400 | 7.055 |
01:03 ET | 200 | 7.06 |
01:06 ET | 372 | 7.08 |
01:08 ET | 294 | 7.07 |
01:17 ET | 200 | 7.05 |
01:19 ET | 1500 | 7.05 |
01:24 ET | 100 | 7.0114 |
01:26 ET | 3651 | 7.0037 |
01:30 ET | 931 | 6.98 |
01:32 ET | 500 | 6.96 |
01:35 ET | 181 | 6.95 |
01:37 ET | 966 | 6.93 |
01:39 ET | 1785 | 6.92 |
01:42 ET | 3139 | 6.9894 |
01:44 ET | 166 | 6.954 |
01:53 ET | 900 | 6.94 |
01:57 ET | 100 | 6.92 |
02:04 ET | 4000 | 6.98 |
02:06 ET | 100 | 6.96 |
02:09 ET | 150 | 6.95 |
02:11 ET | 702 | 6.93 |
02:15 ET | 100 | 6.9274 |
02:20 ET | 200 | 6.96 |
02:24 ET | 207 | 6.97 |
02:27 ET | 100 | 6.99 |
02:29 ET | 100 | 6.97 |
02:31 ET | 100 | 6.99 |
02:33 ET | 100 | 6.98 |
02:36 ET | 100 | 6.99 |
02:38 ET | 200 | 6.97 |
02:42 ET | 7891 | 7.07 |
02:45 ET | 100 | 7.085 |
02:47 ET | 432 | 7.0659 |
02:51 ET | 1200 | 7.08 |
02:58 ET | 1929 | 7.11 |
03:00 ET | 300 | 7.09 |
03:02 ET | 300 | 7.09 |
03:03 ET | 1500 | 7.1 |
03:05 ET | 400 | 7.065 |
03:12 ET | 600 | 7.11 |
03:14 ET | 1628 | 7.14 |
03:16 ET | 700 | 7.12 |
03:21 ET | 200 | 7.09 |
03:23 ET | 1200 | 7.095 |
03:25 ET | 100 | 7.1 |
03:27 ET | 100 | 7.1 |
03:30 ET | 400 | 7.059 |
03:32 ET | 2871 | 7.05 |
03:36 ET | 300 | 7.084 |
03:38 ET | 300 | 7.06 |
03:39 ET | 100 | 7.069 |
03:48 ET | 271 | 7.02 |
03:50 ET | 357 | 7.02 |
03:52 ET | 707 | 7.04 |
03:54 ET | 600 | 7.05 |
03:56 ET | 1704 | 7.04 |
03:57 ET | 1151 | 7.03 |
03:59 ET | 13697 | 7.01 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Candel Therapeutics Inc | 224.9M | -4.1x | --- |
Acrivon Therapeutics Inc | 224.9M | -2.6x | --- |
Kyverna Therapeutics Inc | 226.5M | 0.0x | --- |
Omeros Corp | 227.2M | -1.2x | --- |
Trevi Therapeutics Inc | 228.7M | -8.1x | --- |
Pyxis Oncology Inc | 221.1M | -3.0x | --- |
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $224.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.70 |
Book Value | $0.44 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.